Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from biotechnology

3 Biotech Stocks to Buy for Under $20 Right Now

The need for more advanced biotech research and development has increased amid an aging population and growing medical needs. Investors' sentiment toward biotech stocks has improved significantly over the past months. Given the industry's solid prospects, fundamentally sound biotech stocks Exelixis (EXEL), Innoviva (INVA), and Cidara Therapeutics (CDTX) might be…

StockNews.com

Can we ethically justify harming animals for research? There are several schools of thought

Neuralink, the biotechnology company co-founded by Elon Musk, has been accused of animal cruelty and is under federal investigation in the United States for potential animal welfare violations.

The Conversation

Over 50 Biotech-Kisan Hubs Created By Department Of Biotechnology: Union Min Jitendra Singh

Union Minister Jitendra Singh on Wednesday said that the Department of Biotechnology has funded fifty-one (51) Biotech-Kisan hubs out of which forty-four (44) are operational. Read on for details:

Dynamite News

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Biotech Stocks to Buy Before December and 1 to Sell

The biotech industry is increasingly gaining prominence due to the growing prevalence of chronic disease and advancements in drug discovery and development. Given the industry’s solid growth prospects, it could be wise to buy quality biotech stocks, Gilead Sciences (GILD), Vertex Pharmaceuticals (VRTX), and United Therapeutics (UTHR). However, we think…

StockNews.com

Blue Star (NASDAQ: BSFC) Insiders Are Buying Stock

One indicator of where a company’s stock might be going in the future can be understood by what insiders may be thinking of the Company’s current stock price and near-term future outlook. Insiders are considered C-Suite Executives, a member of the Board of Directors, and anyone (person or company) that…

Benzinga

Is This Biotech Stock a Rising Star in the Making?

Shares of oncology-focused biotechnology company Sonnet BioTherapeutics (SONN) have plummeted more than 70% in price year-to-date due to its poor financials and the broad-based market sell-off. However, the company is advancing its drug candidates via research breakthroughs, clinical trials, and strategic initiatives. Given the company’s constant progress, can this biotech…

StockNews.com

12 Health Care Stocks Moving In Friday's Intraday Session

Gainers

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Investment in China’s New Economy Sectors Shrinks, Caixin Index Shows

The contribution of high value-added industries such as biotechnology to the country’s total economic inputs slipped in October

Caixin Global

$1.9 Million Bet On This Biotechnology Stock? Check Out These 4 Penny Stocks Insiders Are Buying

The Dow Jones dropped by around 100 points on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment…

Benzinga

2 No-Brainer Biotech Stocks to Buy Right Now and 1 to Sell

The biotech industry is set to benefit from continued investments in breakthrough developments and federal support. Against this backdrop, fundamentally strong biotech stocks Gilead Sciences (GILD) and Vertex Pharmaceuticals (VRTX) could be solid buys. However, Relmada Therapeutics (RLMD) might be best avoided considering its weak fundamentals. Read on….

StockNews.com

Will cell-based milk change the dairy industry? This California lab could lead the way

Biotechnology startup TurtleTree wants to change the way people consume milk.

Tribune News Service

Give legal rights to animals, trees and rivers, say experts

Report for Law Society says framework is essential for future interactions with the environment and biotechnology

The Guardian - UK

New rice strain able to tolerate flooding

A research team from the National Centre for Genetic Engineering and Biotechnology (Biotec) has succeeded in developing a new rice strain called Hom Le Noi that can reportedly withstand the effects of flooding.

Bangkok Post

3 Biotech Stocks That'll Make You Richer and 1 That Won't

The biotech industry continues to stay resilient to broader economic challenges. Moreover, the planned multi-million-dollar government investments should bode well for the industry. Hence, quality biotech stocks Amgen (AMGN), Gilead Sciences (GILD), and Biogen (BIIB) could be ideal buys to cash in on the industry’s prospects. However, fundamentally weak stock…

StockNews.com

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

New method of preserving donated kidneys ‘could mean fewer organs wasted’

The technique could keep kidneys viable for longer and increase the number available for transplant.

Foreign Policy

Who’s Afraid of Gene-Edited Crops?

A new U.K. bill is a chance at food security—if Britain can get past unfounded fears.

Benzinga

MingMed Biotech Joins Queue of Revenue-less Drug Startups Seeking IPO Cash

Key Takeaways: With no drug revenues and growing R&D costs, MingMed Biotechnology plans to feed its cash-burning machine with a Hong Kong IPO Company has seven drugs in development, including six in the clinical stages By Ellie Si

Bangkok Post

Agricultural firms urged to accelerate tech adoption

Thai food and agricultural companies are being advised to boost their productivity and food safety through the application of Internet of Things, robotics in value chains, and drone technology for plantation and agricultural biotechnology such as genetic engineering.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

$7.3 Million Bet On This Penny Stock? Check Out These 4 Penny Stocks Insiders Are Buying

The Dow Jones dropped more than 600 points on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment…

Asharq Al-Awsat

Riyadh, Tashkent to Expand Cooperation in Tech, Petrochemical Industries

Ahead of the visit of Uzbek President Shavkat Mirziyoyev to Saudi Arabia, the embassy of Uzbekistan in Riyadh expected a rapid and dynamic development of bilateral cooperation between the two countries. Cooperation is expected in the fields of energy, information technology, telecommunications, health, biotechnology and agriculture, in addition to forestry,…

StockNews.com

5 Biotech Stocks in the Buy Zone This Week

The biotech industry is expected to see solid growth in the long term due to rising healthcare spending, breakthrough developments, and an aging population. Given the industry’s solid growth prospects and non-cyclical nature, it could be wise to invest in fundamentally strong biotech stocks Gilead Sciences (GILD), Biogen (BIIB), Jazz…

Benzinga

Recap Of Friday's Biotech Catalysts - End Of the Day Summary

Pfizer (NYSE:PFE) announced positive top-line results from its pivotal U.S. Phase 3 study in infants evaluating its 20-valent pneumococcal conjugate vaccine candidate (20vPnC) for the prevention of invasive pneumococcal disease (IPD). The study met two co-primary objectives, associated with immunogenicity responses. Pfizer shares traded in a range of $48.55 to…

Benzinga

Biotech Daily: Amgen, Gilead Go Shopping, Nod For AstraZeneca's Lynparza In Early Stage Breast Cancer, Decision Day For Alzheimer's Associated Hallucinations Candidate

Here's a roundup of top developments in the biotech space over the last 24 hours:

StockNews.com

Don't Rule out a Summer Rally for This 1 Biotech Stock

Leading biotechnology company Vertex Pharmaceuticals (VRTX) has achieved strong top and bottom-line growth in its last quarter. Furthermore, the company is well-positioned to benefit from its diversified pipeline of transformative small-molecule, cell, and genetic therapies. Thus, even after gaining 27.5% year-to-date, we think VRTX still has decent upside potential. Read…

StockNews.com

5 Biotech Stocks to Buy and Hold for the Next Decade

The biotech industry seems poised to witness solid growth over the next decade with intensive innovation, breakthrough developments, and growing investments in the sector. So, given analysts’ promising growth outlook for the industry, it could be wise for investors to buy and hold fundamentally solid biotech stocks Vertex Pharmaceuticals (VRTX),…

1 … 8 9 10 11

People

Elon Musk

27,430 stories

Dipanjan BanchurSince

722 stories

Luke

627 stories

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.